As of close of business last night, Coya Therapeutics Inc’s stock clocked out at $9.92, up 2.80% from its previous closing price of $9.65. In other words, the price has increased by $+0.27 from its previous closing price. On the day, 122922 shares were traded.
Ratios:
To gain a deeper understanding of COYA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.15 and its Current Ratio is at 8.15. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 22 ’23 when Lee Ann bought 1,000 shares for $3.62 per share. The transaction valued at 3,620 led to the insider holds 17,479 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, COYA now has a Market Capitalization of 144.41M and an Enterprise Value of 160.23M. For the stock, the TTM Price-to-Sale (P/S) ratio is 24.04 while its Price-to-Book (P/B) ratio in mrq is 4.01. Its current Enterprise Value per Revenue stands at 26.70 whereas that against EBITDA is -21.85.
Stock Price History:
The Beta on a monthly basis for COYA is 0.79, which has changed by 149.62% over the last 52 weeks, in comparison to a change of 27.86% over the same period for the S&P500. Over the past 52 weeks, COYA has reached a high of $10.69, while it has fallen to a 52-week low of $3.21. The 50-Day Moving Average of the stock is 8.11, while the 200-Day Moving Average is calculated to be 5.69.
Shares Statistics:
It appears that COYA traded 94.77K shares on average per day over the past three months and 187.86k shares per day over the past ten days. A total of 14.41M shares are outstanding, with a floating share count of 12.49M. Insiders hold about 14.09% of the company’s shares, while institutions hold 19.41% stake in the company. Shares short for COYA as of Mar 15, 2024 were 46.71k with a Short Ratio of 0.49, compared to 22.27k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.32% and a Short% of Float of 0.35%.
Earnings Estimates
As of right now, 1 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.3 for the current quarter, with a high estimate of -$0.3 and a low estimate of -$0.3, while EPS last year was -$0.28. The consensus estimate for the next quarter is -$0.04, with high estimates of -$0.04 and low estimates of -$0.04.
Analysts are recommending an EPS of between -$0.85 and -$0.85 for the fiscal current year, implying an average EPS of -$0.85. EPS for the following year is -$1.6, with 1 analysts recommending between -$1.6 and -$1.6.
Revenue Estimates
A total of 1 analysts have provided revenue estimates for COYA’s current fiscal year. The highest revenue estimate was $8.4M, while the lowest revenue estimate was $8.4M, resulting in an average revenue estimate of $8.4M. In the same quarter a year ago, actual revenue was $6M, up 40.00% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $10M in the next fiscal year. The high estimate is $10M and the low estimate is $10M. The average revenue growth estimate for next year is up 19.00% from the average revenue estimate for this year.
